4[1]Rowinsky EK,Donehower RC.Paclitaxel (taxol) N Engl J Med 1995; 332:1004-1014
5[2]Chang YF,Li LL,Wu CW,Liu TY,Lui WY,P'eng FK,Chi CW.Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.Cancer 1996; 77:14-18
6[3]Kim YH,Shin SW,Kim BS,Kim JH,Kim JG,Mok YJ,Kim CS,Rhyu HS,Hyun JH,Kim JS.Paclitaxel,5-fluorouracil,and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.Cancer 1999; 85:295-301
7[4]Murad AM,Petroianu A,Guimaraes RC,Aragao BC,Cabral LO,Scalabrini-Neto AO.Phase Ⅱ trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer:a novel,safe,and effective regimen.Am J Clin Oncol 1999; 22:580-586
8[5]Lokich JJ,Sonneborn H,Anderson NR,Bern MM,Coco FV,Dow E,Oliynyk P.Combined paclitaxel,cisplatin,and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.Cancer 1999; 85:2347-2351
9[6]Kollmannsberger C,Quietzsch D,Haag C,Lingenfelser T,Schroeder M,Hartmann JT,Baronius W,Hempel V,Clemens M,Kanz L,Bokemeyer C.A phase Ⅱ study of paclitaxel,weekly,24-hour continous infusion 5-fluorouracil,folinic acid and cisplatin in patients with advanced gastric cancer.Br J Cancer 2000; 83:458-462
10[7]Garcia AA,Leichman CG,Lenz HJ,Baranda J,Lujan R,Casagrande Y,Leichman L.Phase Ⅱ trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic,measurable adenocarcinoma of the stomach.Jpn J Clin Oncol 2001; 31:275-278
